Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 31998R1916

    Commission Regulation (EC) No 1916/98 of 9 September 1998 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance)

    IO L 250, 10.9.1998, p. 8–12 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)

    Foilsíodh an doiciméad seo in eagrán speisialta (CS, ET, LV, LT, HU, MT, PL, SK, SL, BG, RO)

    Legal status of the document No longer in force, Date of end of validity: 05/07/2009; Arna aisghairm go hintuigthe ag 32009R0470

    ELI: http://data.europa.eu/eli/reg/1998/1916/oj

    10.9.1998   

    EN

    Official Journal of the European Communities

    L 250/8


    COMMISSION REGULATION (EC) No 1916/98

    of 9 September 1998

    amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin

    (Text with EEA relevance)

    THE COMMISSION OF THE EUROPEAN COMMUNITIES,

    Having regard to the Treaty establishing the European Community,

    Having regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (1), as last amended by Commission Regulation (EC) No 1570/98 (2), and in particular Articles 6 and 8 thereof,

    Whereas, in accordance with Regulation (EEC) No 2377/90, maximum residue limits must be established progressively for all pharmacologically active substances which are used within the Community in veterinary medicinal products intended for administration to food-producing animals;

    Whereas maximum residue limits should be established only after the examination within the Committee for Veterinary Medicinal Products of all the relevant information concerning the safety of residues of the substance concerned for the consumer of foodstuffs of animal origin and the impact of residues on the industrial processing of foodstuffs;

    Whereas, in establishing maximum residue limits for residues of veterinary medicinal products in foodstuffs of animal origin, it is necessary to specify the animal species in which residues may be present, the levels which may be present in each of the relevant meat tissues obtained from the treated animal (target tissue) and the nature of the residue which is relevant for the monitoring of residues (marker residue);

    Whereas, for the control of residues, as provided for in appropriate Community legislation, maximum residue limits should usually be established for the target tissues of liver or kidney, whereas, however, the liver and kidney are frequently removed from carcases moving in international trade, and maximum residue limits should therefore also always be established for muscle or fat tissues;

    Whereas, in the case of veterinary medicinal products intended for use in laying birds, lactating animals or honey bees, maximum residue limits must also be established for eggs, milk or honey,

    Whereas toltrazuril and amitraz should be inserted into Annex I to Regulation (EEC) No 2377/90;

    Whereas clazuril, aluminium distearate, aluminium hydroxide acetate, aluminium phosphate, aluminium tristearate, ammonium chloride, cobalt carbonate, cobalt dichloride, cobalt gluconate, cobalt oxide, cobalt sulphate, cobalt trioxide, iron sulphate, terebinthinae laricina, coco alkyl dimethyl betaines, diprophylline, hexetidine, polyethylene glycol 15 hydroxystearate, polyethylene glycol 7 glyceryl cocoate, polyethylene glycol stearates with 8-40 oxyethylene units, prethcamide (crotethamide, cropropamide), terpin hydrate, balsamum peruvianum, oxidation products of terebinthinae oleum, ricini oleum and terebinthinae aetheroleum rectificatum and iron dichloride should be inserted into Annex II to

    Regulation (EEC) No 2377/90;

    Whereas a period of 60 days should be allowed before the entry into force of this Regulation in order to allow Member States to make any adjustment which may be necessary to the authorisations to place the veterinary medicinal products concerned on the market which have been granted in accordance with Council Directive 81/851/EEC (3), as last amended by Directive 93/40/EEC (4), to take account of the provisions of this Regulation;

    Whereas the measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

    HAS ADOPTED THIS REGULATION:

    Article 1

    Annexes I and II to Regulation (EEC) No 2377/90 are hereby amended as set out in the Annex hereto.

    Article 2

    This Regulation shall enter into force on the 60th day following its publication in the Official Journal of the European Communities.

    This Regulation shall be binding in its entirety and directly applicable in all Member States.

    Done at Brussels, 9 September 1998.

    For the Commission

    Martin BANGEMANN

    Member of the Commission


    (1)  OJ L 224, 18. 8. 1990, p. 1.

    (2)  OJ L 205, 22. 7. 1998, p. 10.

    (3)  OJ L 317, 6. 11. 1981, p. 1.

    (4)  OJ L 214, 24. 8. 1993, p. 31.


    ANNEX

    A.

    Annex I to Regulation (EEC) No 2377/90 is amended as follows:

    2.

    Anti-parasitic agents

    2.2.

    Agents acting against ectoparasites

    2.2.2.

    Formamidines

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    ‘Amitraz

    Sum of amitraz and all metabolites containing the 2,4-DMA moeity, expressed as amitraz

    Bovine

    200 μg/kg

    Fat

     

    200 μg/kg

    Liver

    200 μg/kg

    Kidney

    10 μg/kg

    Milk

    Ovine

    400 μg/kg

    Fat

    100 μg/kg

    Liver

    200 μg/kg

    Kidney

    10 μg/kg

    Milk’

    2.4.

    Agents acting against protozoa

    2.4.1.

    Triazinetrione derivative

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    Other provisions

    ‘Toltrazuril

    Toltrazuril sulfone

    Chicken

    100 μg/kg

    Muscle

    Not for use in animals from which eggs are produced for human consumption’

    200 μg/kg

    Skin + fat

    600 μg/kg

    Liver

    400 μg/kg

    Kidney

    Turkey

    100 μg/kg

    Muscle

    200 μg/kg

    Skin + fat

    600 μ/kg

    Liver

    400 μg/kg

    Kidney

    B.

    Annex II to Regulation (EEC) No 2377/90 is amended as follows:

    1.

    Inorganic chemicals

    Pharmacologically active substance(s)

    Animal species

    Other provisions

    ‘Aluminium distearate

    All food producing species

     

    Aluminium hydroxide acetate

    All food producing species

     

    Aluminium phosphate

    All food producing species

     

    Aluminium tristearate

    All food producing species

     

    Aluminium chloride

    All food producing species

     

    Cobalt carbonate

    All food producing species

     

    Cobalt dichloride

    All food producing species

     

    Cobalt gluconate

    All food producing species

     

    Cobalt oxide

    All food producing species

     

    Cobalt sulphate

    All food producing species

     

    Cobalt trioxide

    All food producing species

     

    Iron dichloride

    AH food producing species

     

    Iron sulphate

    All food producing species’

     

    2.

    Organic compounds

    Pharmacologically active substance(s)

    Animal species

    Other provisions

    ‘Clazuril

    Pigeon

     

    Coco alkyl dimethyl betaines

    All food producing species

    For use as excipient

    Diprophylline

    All food producing species

     

    Hexetidine

    Equidae

    For topical use only

    Polyethylene glycol 15 hydroxystearate

    All food producing species

    For use as excipient

    Polyethylene glycol 7 glyceryl cocoate

    All food producing species

    For topical use only

    Polyethylene glycol stearates with 8-40 oxyethylene units

    All food producing species

    For use as excipient’

    Prethcamide (crotethamide and cropropamide)

    All mammalian food producing species

     

    Terpin hydrate

    Bovine, porcine, ovine, caprine

     

    6.

    Substances of vegetable origin

    Pharmacologically active substance(s)

    Animal species

    Other provisions

    Balsamum peruvianum

    All food producing species

    For topical use only

    Oxidation products of terebinthinae oleum

    Bovine, porcine, ovine, caprine

     

    Ricini oleum

    All food producing species

    For use as excipient

    Terebinthinae aetheroleum rectificatum

    All food producing species

    For topical use only

    Terebinthinae laricina

    All food producing species

    For topical use only’


    Top